These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21749453)

  • 1. Immunohistochemical subclassification of thyroid tumors with a prominent hyalinizing trabecular pattern.
    Lee S; Hong S; Koo JS
    APMIS; 2011 Aug; 119(8):529-36. PubMed ID: 21749453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China.
    Song Q; Wang D; Lou Y; Li C; Fang C; He X; Li J
    Diagn Pathol; 2011 Dec; 6():126. PubMed ID: 22188859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyalinizing trabecular adenoma of the thyroid revisited: a histologic and immunohistochemical study of thyroid lesions with prominent trabecular architecture and sclerosis.
    Galgano MT; Mills SE; Stelow EB
    Am J Surg Pathol; 2006 Oct; 30(10):1269-73. PubMed ID: 17001158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical characteristics of diffuse sclerosing variant of papillary carcinoma: comparison with conventional papillary carcinoma.
    Koo JS; Shin E; Hong SW
    APMIS; 2010 Oct; 118(10):744-52. PubMed ID: 20854468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
    Tan A; Etit D; Bayol U; Altinel D; Tan S
    Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
    Ceyran AB; Şenol S; Şimşek BÇ; Sağıroğlu J; Aydın A
    Int J Clin Exp Pathol; 2015; 8(4):3670-80. PubMed ID: 26097548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of CK19, HBME-1 and galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions].
    Tong J; Wang Y; Da JP
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):599-604. PubMed ID: 22325220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyalinizing trabecular adenoma of the thyroid gland--a report of two cases.
    Lewy-Trenda I; Wierzchniewska-Lawska A
    Pol J Pathol; 1999; 50(4):301-3. PubMed ID: 10721271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic usefulness of HBME1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma.
    Scognamiglio T; Hyjek E; Kao J; Chen YT
    Am J Clin Pathol; 2006 Nov; 126(5):700-8. PubMed ID: 17050067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of HBME-1, CD56, Galectin-3 and Cytokeratin-19 in papillary thyroid carcinomas and thyroid tumors of uncertain malignant potential.
    Nechifor-Boilă A; Cătană R; Loghin A; Radu TG; Borda A
    Rom J Morphol Embryol; 2014; 55(1):49-56. PubMed ID: 24715165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyalinizing trabecular tumor and papillary carcinoma of the thyroid.
    Zhu H; Qi JP; Wang YW; Song YJ; Zhang ZY
    Chin Med J (Engl); 2010 Oct; 123(20):2832-5. PubMed ID: 21034592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid tumors of uncertain malignant potential: morphologic and imunohistochemical analysis of 29 cases.
    Nechifor-Boila A; Borda A; Sassolas G; Hafdi-Nejjari Z; Cătană R; Borson-Chazot F; Berger N; Decaussin-Petrucci M
    Pathol Res Pract; 2015 Apr; 211(4):320-5. PubMed ID: 25595997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of CK19 and CD56 in the differentiation of thyroid papillary carcinoma from its mimics.
    Abouhashem NS; Talaat SM
    Pathol Res Pract; 2017 May; 213(5):509-517. PubMed ID: 28214214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyalinizing trabecular tumor of thyroid: a clinicopathologic study].
    Chen B; Li CS; Zhang G; Yin WJ; Zhao JQ; Chen JY; Sun WY
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):560-1. PubMed ID: 23157751
    [No Abstract]   [Full Text] [Related]  

  • 15. [The morphological and immunohistochemical features and malignancy potential of a hyalinizing trabecular tumor of the thyroid].
    Abrosimov AIu; Dvinskikh NIu; Makanin MA; mal'kov PG; Grinevich VN
    Arkh Patol; 2009; 71(6):36-9. PubMed ID: 20131505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical markers in the diagnosis of papillary thyroid carcinomas: The promising role of combined immunostaining using HBME-1 and CD56.
    Nechifor-Boila A; Borda A; Sassolas G; Hafdi-Nejjari Z; Borson-Chazot F; Lifante JC; Sturm N; Lavérriere MH; Berger N; Decaussin-Petrucci M
    Pathol Res Pract; 2013 Sep; 209(9):585-92. PubMed ID: 23910176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.
    Rossi G; Marchioni A; Milani M; Scotti R; Foroni M; Cesinaro A; Longo L; Migaldi M; Cavazza A
    Am J Clin Pathol; 2004 Dec; 122(6):884-93. PubMed ID: 15595193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyalinizing trabecular adenoma of the thyroid gland.
    Bishop JA; Ali SZ
    Diagn Cytopathol; 2011 Apr; 39(4):306-10. PubMed ID: 20730896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyalinizing trabecular tumor of the thyroid: a clinicopathological analysis of four cases and review of the literature.
    Liu Y; Huang X; Hu Y; Wang F; Du T; He W; Chen L; Lang B; Pu Q; Chen H
    Int J Clin Exp Pathol; 2017; 10(7):7616-7626. PubMed ID: 31966606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.